Compared to Estimates, Omada Health, Inc. (OMDA) Q3 Earnings: A Look at Key Metrics

07.11.25 00:00 Uhr

Werte in diesem Artikel

For the quarter ended September 2025, Omada Health, Inc. (OMDA) reported revenue of $68.03 million, representing no change compared to the same period last year. EPS came in at $0.02, compared to $0 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $61.15 million, representing a surprise of +11.25%. The company delivered an EPS surprise of +120%, with the consensus EPS estimate being -$0.10.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Omada Health, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Total Members: 831,000 versus the two-analyst average estimate of 779,290.Revenue- Hardware: $5.09 million versus $4.44 million estimated by two analysts on average.Revenue- Services: $62.94 million compared to the $56.71 million average estimate based on two analysts.View all Key Company Metrics for Omada Health, Inc. here>>>Shares of Omada Health, Inc. have returned -2.8% over the past month versus the Zacks S&P 500 composite's +1.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Omada Health, Inc. (OMDA): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Omada Health

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Omada Health

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Omada Health Incorporation Registered Shs

Wer­bung